#stem cell treatment for knee osteoarthritis in the UK | Explore Tumblr posts and blogs

medicastemcellsuk · 4 years ago

Text

How To Heal Knee Arthritis Pain With Regenerative Treatment?

Knee pain is a very common symptom prevalent among not only the elders but also the younger ones. Arthritis is the most common cause of knee pain.

There are two types of knee arthritis such as osteoarthritis and rheumatoid arthritis. Osteoarthritis is a degenerative condition, otherwise called wear-and-tear arthritis. The cartilage gives a cushion-like effect between the bone joints. In osteoarthritis, wear and tear activities remove the cartilage gradually. Hence, joint bones run against each other, which leads to knee pain. In rheumatoid arthritis, the immune system attacks itself by damaging the cartilage. As and when the knee pain becomes severe, the muscles around the affected knee portion weaken. Hence, this condition leads to joint deformity where the knee shape may point inwards or outwards.

Knee arthritis not only causes pain. It is also accompanied by other symptoms like tenderness, limited range of motion, stiffness, swelling, warmth sensation and cracking noise, especially while climbing the steps.

Causes of Knee Arthritis

Knee arthritis is more common among females compared to males. The varied causes of knee arthritis include previous joint injuries, trauma, obesity, bone deformities, strenuous activities with repetitive movements, genetics, family history, Vitamin D and calcium deficiency. Over secretion of growth hormone and iron overload increase the risk to develop knee arthritis.

Diagnosis of Knee Arthritis

Knee arthritis can be diagnosed by performing a physical examination and an X-ray scan. If the pain is severe, the physician may opt for an MRI scan for a detailed examination of bones, cartilage and soft bones. The physician will suggest a synovial fluid examination or blood test to detect rheumatoid arthritis.

Treatment for Knee Arthritis

The preliminary treatment measures for knee pain include R.I.C.E. therapy and medications to control the symptoms and avoid further joint damage. The home-based treatment named R.I.C.E. formula comprises of Rest, Ice therapy, Compression and Elevation. Medications such as analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) provide only short-term relief.

If the pain continues, the physician may recommend the administration of corticosteroid injections, but they can also provide only temporary relief with few side effects. Prolonged use of corticosteroid injections will suppress the body’s natural healing mechanism, and the patient may end up with knee replacement surgery.

Surgery will be the last resort if there is no significant improvement in symptoms. Various surgical procedures include knee arthroscopy, joint distraction, knee osteotomy and partial or total joint replacement. But surgery involves an extensive post-rehabilitation period, with a chance of another surgery in the future. You may have to undergo activity modification, such as reducing knee bending and climbing stairs. Follow up physical therapy, muscle strengthening exercises or use assistive devices like canes, after you get relief from knee pain. Dietary changes that aim at weight reduction may prevent the condition from getting worse.

Regenerative treatment can put an end to your long-lasting symptoms by repairing the damaged cells and restoring the normal function. Regenerative therapy is a non-surgical procedure with minimal downtime. It enhances recovery within a short period by stimulating your body’s healing mechanism naturally. The regenerative treatment has no side effects since it involves your own stem cells or blood cells. Hence, there is neither any rejection issues nor any cross-transmission of disease.

Regenerative treatment includes Platelet Rich Plasma (PRP) therapy, Prolotherapy, SVF (Stromal Vascular Fraction) cell therapy and Mesenchymal cell therapy.

It is essential to treat the cause of the disease, instead of suppressing the related symptoms. This is where regenerative treatment proves to be safe and effective; it naturally treats the underlying cause.

For more information about the Regenerative Treatment for Knee Pain, You can also contact Medica Stem Cells clinic in London to learn more about the types of regenerative cell therapies, PRP Treatment in London available in the UK to treat knee arthritis.

1 note · View note

rajyog7493 · 3 years ago

Text

What Impacted COVID-19 on Knee Cartilage Repair ?

Impact of COVID-19 on Knee Cartilage Repair in Healthcare Industry

The novel coronavirus/COVID-19 pandemic had significantly impacted almost all industries across the globe. This pandemic has resulted in mass production shutdowns and supply chain disruptions, which has also affected the economy.

The lockdown of countries lead to decreased number of knee cartilage repair surgeries as they are non-essential in comparison with the emergent services required by people affected with COVID-19. According to the weekly epidemiological report of 27th September 2020 by World Health Organization (WHO) stated 32.7 million cases of corona has been reported globally, and 991,000 patients are dead due to the coronavirus. However, 6,720,771 cases are reported in South-East Asia only, and 110,711 people died due to coronavirus. Moreover, 600,891 cases are reported in Western Pacific and 13,129 people died due to coronavirus. The implications of COVID-19 having considerable influence on the knee cartilage repair market are now starting to be felt. Various factors which have indirect influence on the decline in medical aesthetics procedures along with the decline in the adoption of knee cartilage repair include flight cancellations, travel bans, mass quarantine along with growing panic among the population, and uncertainty about future.

The COVID-19 for a longer period has adversely affected the most vulnerable groups of population, including geriatric, mothers, and children. Globally, countries are expecting drastic decline in dietary quality in low- and middle-income countries as a result of loss of income, shutdown of businesses, human and goods movement restrictions imposed by governments, de-globalization, and breakdown of food markets due to both demand shocks and supply constraints. This disease has a variable impact in different countries depending on their cultural norms, mitigation efforts, and health infrastructure, and each country is working its way out to fight against the pandemic.

The COVID-19 outbreak will impact the knee cartilage repair market in the initial phase of the forecast period. Due to nationwide lockdowns, denied orthopedic services, and cancelled or postponed elective surgeries, the knee cartilage repair market is expected to decline during the initial phase of the forecasted period. However, during the latter half of the forecast period, the demand for knee cartilage repair products is expected to rise drastically.

Impact on Demand

Elective surgeries are being denied (canceled/postponed) to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) towards COVID-19 patient care. Moreover, various countries have enforced lockdowns and curfews to curb the rising number of positive COVID-19 cases. The lockdowns, has affected the demand for knee cartilage repair surgeries during 2020; however, this demand is expected to rise exponentially in the latter half of the forecasted period. Due to lockdowns in Q1 and Q2 of 2020, the number of elective surgeries performed significantly reduced. This has dramatically reduced the sales of knee cartilage repair products in Q1 and Q2 of 2020. On average, the growth rate declined by 20−30% in the last six months.

The key players are heavily investing in projects related to knee cartilage repair during these crises. These all factors are predicted to boost the market growth during the COVID-19 pandemic

For instances,

· In June 2021 DJO, LLC Acquired Mathys AG Bettlach, a Switzerland-based company that develops and distributes innovative products for artificial joint replacement

· In April 2021, Stryker has partnered with Minor League Baseball and became the Official SmartRobotics Joint Replacement Partner. Stryker has launched the latest innovation in joint replacement technology, Mako SmartRobotics which uses a 3D CT-Based planning software for hip and knee replacement. It helps the surgeons to create a 3D image of each patient’s unique anatomy

· In March 2021, DJO, LLC made investment in Insight Medical Systems (“Insight”), a technology company dedicated to wearable surgical navigation in orthopedics. For Next-Generation Augmented Reality Technology

· In March 2021, Smith-Nephew and Huma The digital technology has developed a remote patient monitoring app for orthopaedic surgery. Due to COVID-19, the UK surgeries are running at 50% of usual capacity, due to which there are about 250000 patients on waiting lists for orthopaedic operations. In order to restart the safe surgery, the company along with Huma as developed a way for surgeons to prepare their patients in a better way through remote patient monitoring by app

· In May 2020, MEDIPOST Co., Ltd. announced the completion of administration of all subject in the phase 1 clinical study of intra-articular injectable knee osteoarthritis cell therapy product, which is being developed as second-generation stem cell therapy product for knee osteoarthritis

Impact on Supply

The COVID-19 outbreak has disrupted the supply chains for the entire manufacturing sector. According to the Institute for Supply Chain Management, 75% of the companies reported the disruptions in the supply chain due to restrictions in the transportation by the coronavirus. Also, 50% of the companies reported the unexpected delays in receiving orders, a problem compounded by supply chain information blackout from the China.

The sudden outbreak of COVID-19 and its subsequent impact on restrictions on trade and movement of goods has resulted in the shutdown of vast portions of the global economy, resulting in disrupted supply chains due to limited materials and workforce and slowdown or stopping of manufacturing. Moreover, several medical equipment manufacturing companies are retooling for priority manufacturing to produce other essential medical supplies and equipment such as ventilators.

The trade restrictions have left no choice but making domestic manufacturing of essential medical devices a necessity. During the pandemic, as the demand increases, counterfeiting and price gouging of imported goods increase.

The COVID-19 situation has led to disrupted supply chains for knee cartilage repair market. The shortage of the instruments used in the surgery, along with no access to healthcare facilities where these surgeries could be done, leads to decreased availability of such procedures. This means that the supply of knee cartilage repair surgeries is limited in situations where their demand is high.

Impact on Price

Due to the pandemic, there is delay associated with various types of limitations faced by the manufacturers to fulfill the end product order, which has resulted in the less availability of products in the market and due to which the cost of available products has increased with the several factors. Also, due to the coronavirus disease (COVID-19) pandemic outbreak, manufacturers are forced to find new contract manufacturers and suppliers for move manufacturing activities to different or unique facilities locations that are less impacted by outbreaks.

The current COVID-19 episode has influenced essentially every industry, and knee cartilage repair is no exemption. There has been a tremendous and sudden lessening in the volume knee cartilage repair surgeries worldwide as wellbeing situation legitimately organize their COVID-19 reaction.

In current situations, the manufactures of knee cartilage repair products are facing difficulties with existing component suppliers or contracts, manufacturers which are at risk or closed or not being able to fulfill supply requirements due to challenges such as extended periods of shut down or workforce are responsible for price fluctuation of knee cartilage repair products.

Strategic Decisions of Government and Manufacturers

During this time of crisis, Considering recent announcements from the World Health Organization (WHO), the Centers for Disease Control (CDC), as well as local government agencies, several key players of knee cartilage repair market across the globe are making changes in their policies for their employees.

· In March 2020, ISTO Technologies Inc. announced that all Isto employees have been encouraged to work from home for the foreseeable future should their specific role allow it. We will continue to follow the guidelines of local, state, and federal governments to ensure we are doing our part in slowing the spread of COVID-19

· In 2020, Smith+Nephew done partnership with Tharsus to improve workplace safety and use anonymous employee data to inform effective social-distancing

· In 2020, Stryker team at medical division came together to develop a low-cost, readily available bed to ship to hospitals quickly, as caregivers faced the unprecedented need for additional equipment on the frontlines of the COVID-19 crisis. Also, donated more than 22,500 Emergency Relief Bed Kits to Project C.U.R.E

Conclusion

The desire of the patients for the knee cartilage repair treatment is strong but the practice must gain the trust and loyalty to offset the economic concerns after the COVID-19 situation. Each market is presented with individual barriers but to gain back the normality, those barriers are needed to be overcome. Along with the barriers, many opportunities will come with challenges which will aid in surging the market again. The decline in the demand for surgery is seen in order to minimize the spread of the virus and to use the resources preferentially for emergent procedures. Moreover, the government imposed lockdown in various countries across globe, further added to the burden of decline in the demand for the surgery.

Concerns directly linked to COVID-19 such as personal touch, social distancing problems, or PPE concerns were recorded by 51 percent of patients with income conditions and affordability closely behind among 44 percent. Promotions and deals are one potential strategy to re-engage selected patients. Finance is a barrier to entry, with respondents concerned about potential economic changes affecting their previous routines. However, considering the use of payment plans, concerns related to intimate contact, social distancing, or PPE concerns related to income situation and affordability for cleaning protocols grouped treatment options or “bolt-on” style treatment deals, coupled with new safety measures may help patients feel comfortable, reassured and confident to return to aesthetic treatments as knee cartilage repair.

Although COVID-19 continues to raise obstacles for the sector, clinics and clinicians should adopt the lessons to ensure stable, reliable, and secure procedures and continuing correspondence to help inform patients and promote a timely return to care once clinics are re-opened.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

#COVID-19 Impact on Knee Cartilage Repair Market Price #COVID-19 Impact on Knee Cartilage Repair Market Demand #COVID-19 Impact on Knee Cartilage Repair Market Supply #Healthcare Industry #COVID-19 Impact

0 notes

healthcareindustrynews · 3 years ago

Text

Cartilage Repair Market: Industry Trends and Opportunities

This report aims to provide detailed insights into the global cartilage repair market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Expected Revenue Growth Analysis: The Cartilage Regeneration Market is projected to reach USD 1,603 million by 2025 from USD 787 million in 2020, at a CAGR of 15.3% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272 Key Factors Driving Market Growth: The growth of cartilage repair market is primarily driven by the increasing incidence of osteoarthritis and increasing funding and investments for research in this field. The cell-based segment accounted for the largest share of the treatment modality segment in the cartilage repair market in 2019. Based on the treatment modality, the cartilage regeneration market is segmented into cell-based and non-cell-based approaches. The non-cell-based segment is divided into tissue scaffolds and cell-free composites. In 2019, the cell-based segment accounted for the largest share of the cartilage regeneration industry. The large share of this segment can be attributed to technological advancements in stem cell-based therapies for cartilage repair and chondrocyte implantation products. Driver: Increasing Incidence of Osteoarthritis: Over the years, the incidence of osteoarthritis has increased across the globe. According to a study by the University of North Carolina, around 1 million knee and hip replacement procedures are conducted every year in the US. The economic burden of osteoarthritis in the US is ~136.8 billion annually. As per the Arthritis Foundation in 2019, degenerative joint diseases such as osteoarthritis will affect more than 130 million patients worldwide by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and Scaffolds implants Thus, the increasing incidence of osteoarthritis is expected to drive the demand for cartilage repair and regeneration products. The Asia Pacific region is the fastest growing region of the cartilage repair market in 2019. The Asia Pacific region is estimated to grow at the highest CAGR in the cartilage regeneration market during the forecast period, this is mainly due to the rising geriatric population and the subsequent increase in the incidence of various disorders and injuries. Recent developments in tissue engineering and stem cell therapy will further fuel market growth. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=37493272 Prominent players in the cartilage regeneration market are Smith & Nephew plc (UK), DePuy Synthes (US), Zimmer Biomet (US), CONMED Corporation (US), Stryker Corporation (US), and Vericel Corporation (US). Extensive primary research was conducted after acquiring basic knowledge about the global cartilage regeneration market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand (such as personnel from the pharmaceutical and biopharmaceutical industry) and supply sides (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, and distributors) across four major regions—North America, Europe, Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively.

#cartilage repair market

0 notes

mangeshp7793 · 3 years ago

Text

How COVID-19 Impacted on Knee Cartilage Repair in Healthcare Industry ?

COVID-19 Impact on Knee Cartilage Repair in Healthcare Industry

Impact on Demand

The key players are heavily investing in projects related to knee cartilage repair during these crises. These all factors are predicted to boost the market growth during the COVID-19 pandemic

For instances,

· In June 2021 DJO, LLC Acquired Mathys AG Bettlach, a Switzerland-based company that develops and distributes innovative products for artificial joint replacement

Impact on Supply

Impact on Price

Strategic Decisions of Government and Manufacturers

· In 2020, Smith+Nephew done partnership with Tharsus to improve workplace safety and use anonymous employee data to inform effective social-distancing

Conclusion

#Knee Cartilage Repair Market #Knee Cartilage Repair Market Analysis #Knee Cartilage Repair Market Size #Knee Cartilage Repair Market Forcast

0 notes

sandlerresearch · 4 years ago

Text

Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Cell based Type (Chondrocyte Transplantation, Growth Factor), Non-Cell (Tissue Scaffolds)), Application (Hyaline), End User (ASCs, Clinic), Site (Knee) - Global Forecast to 2025 published on

https://www.sandlerresearch.org/cartilage-repair-cartilage-regeneration-market-by-treatment-modalities-cell-based-type-chondrocyte-transplantation-growth-factor-non-cell-tissue-scaffolds-application-hyaline-end-user-as.html

“increasing incidence of osteoarthritis is set to drive the cartilage repair and regeneration market.’’

The global cartilage repair and regeneration market is projected to reach USD 1,603 million by 2025 from USD 787 million in 2020, at a CAGR of 15.3% during the forecast period. The growth of this market is primarily driven by the increasing incidence of osteoarthritis and increasing funding and investments for research in this field.

“By cell-based treatment modality, the chondrocyte transplantation segment accounted for the largest share of the cartilage repair and regeneration market”

Based on the treatment modality, the cartilage repair and regeneration market is segmented into cell-based and non-cell-based approaches. The cell-based segment is further divided into chondrocyte transplantation, growth factors, and stem cells. The chondrocyte transplantation segment accounted for the largest share of this market in 2019, owing to greater longevity and utility for larger lesions.

“By application site segment, the knee segment accounted for the fastest growing segment of the cartilage repair and regeneration market”

Based on the application site, the cartilage repair and regeneration market is segmented into knee, hip, ankle and foot, and other application sites (nose and shoulder). The knee segment is estimated to be the fastest growing application site segment of the global cartilage repair and regeneration market. This can be attributed to the growing number of knee arthroscopy procedures and the increasing incidence of knee osteoarthritis.

“Asia Pacific: The fastest-growing region in the cartilage repair and regeneration market.”

The Asia Pacific region is estimated to grow at the highest CAGR in the cartilage repair and regeneration market during the forecast period, this is mainly due to the rising geriatric population and the subsequent increase in the incidence of various disorders and injuries. Recent developments in tissue engineering and stem cell therapy will further fuel market growth.

“North America: the largest share of the cartilage repair and regeneration market”

North America accounted for the largest share of the global market, followed by Europe. The large share of the North American region can be attributed to the high burden of osteoarthritis, increasing prevalence of sports injuries, and increasing research investments in the US and Canada.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:

By Respondent– Supply Side- 80%, Demand Side-20%

By Designation— CXOs- 20%, Executives – 25%, Mangers – 55%

By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The cartilage repair and regeneration market is dominated by a few globally established players such as Arthrex, Inc. (US), Smith & Nephew plc (UK), DePuy Synthes (US), Stryker Corporation (US), CONMED Corporation (US), Zimmer Biomet Holdings, Inc. (US), RTI Surgical, Inc. (US), B. Braun Melsungen AG (Germany), Vericel Corporation (US), Anika Therapeutics (US), Geistlich Pharma AG (Switzerland), Regrow Biosciences (India), MEDIPOST Co., Ltd (South Korea), AlloSource (US), BioTissue SA (Switzerland), and Orthocell (Australia).

Research Coverage:

The report segments the cartilage repair and regeneration market based on region (Asia Pacific, Europe, North America, and RoW), Treatment Modality (cell-based and non-cell-based approaches), Application (hyaline cartilage and fibro cartilage), End User (hospitals and ambulatory surgery centers & clinics) and Application Site (knee, hip, ankle and foot, nose, and shoulder). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges and trends in the cartilage repair and regeneration market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cartilage repair and regeneration market and provides them information on key market drivers, restraints, challenges, and opportunities.

#Biotechnology

0 notes

shristipbi · 5 years ago

Text

Knee Cartilage Repairing Market Growth, Future Opportunities And Forecast to 2025

The global knee cartilage repairing market is expected to reach US$ 7,098.2 Mn by 2025. Cartilage is the rubbery and soft material present in bone joints and precludes the friction between the bones. The aspects which are streaming the growth of global knee cartilage repairing market are increasing elderly population, rising incidence of sports injuries, and upsurge in the obese population. According to World Health Organization around 1.25 million people die each year in road accidents globally and more than 3.5 Mn athletes receives treatment due to sports injuries every year as per American Orthopedic Society for Sports Medicine. Moreover, the increasing prevalence of osteoarthritis, osteoporosis, and other bone disorders are leading the growth of knee cartilage repairing market over the coming period. Furthermore, advancements in the technology, accumulative demand for minimally invasive surgical products, and the upsurge in number of accidents are the vital factors heightening the growth of global knee cartilage repairing market. On the contrary, the high cost of the treatment and disapproving compensation scenario are the chief limiting factors of the global knee cartilage repairing market. Complications regarding the cartilage repair surgeries are also projected to hinder the growth of global knee repairing market over the forecast period.

Global knee cartilage repairing market is segmented on the basis of treatment modality, application, procedure type, end user, and region.

Request for sample report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16271

Cell Based Treatment Modality Dominate the Global Knee Cartilage Repairing Market

Based on the treatment modality type, global knee cartilage repairing market is segmented into cell based and non-cell based approaches. The cell based approaches ruled the global knee cartilage repairing market. Technological advancements in cell-based cartilage restoration have delivered the surgeon a means to address focal cartilage lesions to restore hyaline cartilage.

North America Leads the Global Knee Cartilage Repairing Market

PBI’s global knee cartilage repairing market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global knee cartilage repairing market through 2014-2018 and expected to dominate over 2019-2025. The aspects which are accountable for the growth of knee cartilage repairing market in the region are an escalation in geriatric population coupled with rapid degenerative changes in the knees. Additionally, the growth of the knee cartilage repairing market is partially motivated by the prolonged access to health insurance coverage in the USA. Existence of major key market players in the region coupled with the high per capita income of their people are also surging the growth of global knee cartilage repairing market in the region. After North America, Europe leads the global knee cartilage repairing market due to rising frequency of osteoporosis in France, UK and Germany. For instance, according to National Health Service (NHS), over 3 Mn people are affected by osteoporosis in the UK annually. Moreover, the presence of accomplished healthcare professionals as well as rising occurrence of bone and joint disorders is estimated to create the huge demand for knee cartilage repairing market in Europe region. Asia Pacific is also profitable region for knee cartilage repairing market’s growth owing to rise in incidence of osteoporosis in Australia and New Zealand, growing demand for elderly care, and there increasing geriatric population. As per International Osteoporosis Foundation (IOF) 2.2 million Australians are affected by osteoporosis. Latin America and Middle East & Africa region are anticipated to propel the demand for cartilage repair products during the forecast years owing to upsurge in obese (overweight) population.

Launch of newer treatment modalities, mergers, collaborations, and strategic alliances are the key strategies adopted by market players

Global knee cartilage repairing market further reveals that the key player’s increasingly adopting strategies such as product approvals and launch, mergers, collaboration, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

Ø For instance, in January 2016, Smith & Nephew plc announced the acquisition of “BST-CarGel” from Primal Healthcare which is a first line cartilage repair product for the treatment of focal cartilage tears.

Ø Additionally, In December 2016, FDA approved the autologous cultured chondrocytes on porcine collagen membrane (Maci) by Vericel corporation for symptomatic repair, full-thickness cartilage defects of knee in the adults.

Key player’s profiles in the report are Medtronic (USA), Biomet, Inc. (Zimmer Biomet Inc.) (USA), ConMed Corporation (USA), Depuy Synthes (Johnson and Johnson Services, Inc.) (USA), Arthrex, Inc. (USA), Smith & Nephew PLC (UK), LifeNet Health, Inc. (USA), Primal Healthcare (Canada), Anika Therapeutics, Inc. (USA), Stryker Corporation (USA), and Vericel Corporation (USA).

Precision Business Insights (PBI) in its report titled “Global Knee Cartilage Repairing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation

By Treatment Modality

· Cell Based Approaches

o Chondrocyte Transplantation

o Growth Factor Technology

o Stem Cells

· Non-cell Based Approaches

o Tissue Scaffolds

o Cell-free Composites

By Application

· Hyaline Cartilage

· Fibrocartilage

By Procedure Type

· Arthroscopic Chondroplasty

· Osteochondral Grafts Transplantation

· Autologous Chondrocyte

· Implants Transplant

· Cell-based Cartilage Resurfacing

· Microfracture

· Others

By End User

· Hospital & Clinics

· Ambulatory Surgical Centers

· Orthopedic Clinics

Geography

o North America

· USA

· Canada

o Europe

· Germany

· France

· UK

· Italy

· Spain

· Russia

· Poland

· Rest of Europe

o Asia-Pacific

· Japan

· China

· India

· Australia & New Zealand

· ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

· South Korea

· Rest of Asia-Pacific

o Latin America

· Brazil

· Mexico

· Argentina

· Rest of Latin America

o Middle East and Africa (MEA)

· Gulf Cooperation Council (GCC) Countries

· Israel

· South Africa

· Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-knee-cartilage-repairing-market/

About Us

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

0 notes

millionmarketresarch-blog · 5 years ago

Text

Orthobiologics Market Share | Latest Trends | Outlook 2025

22th May 2019: the global Orthobiologics Market size was valued at USD 5.0 Billion in 2015 and is anticipated to reach USD 10.2 billion by 2025, with a CAGR of 7.5%. Orthobiologics are elements which the orthopedic surgeons use to heal the wounds more quickly. They are utilized for the healing of injured muscles, ligaments, tendons, and broken bones. They are made up of substances found in the human body itself. These elements found popularity owing to factor such as faster healing, quick recovery, and a decrease in the number of hospital visits. The orthobiologics market provides a huge number of opportunities for growth to its shareholders.

The global orthobiologics market is poised for growth owing to the increased levels of geriatric population, technological advancements, changing lifestyles and problems related to the musculoskeletal system. The increasing trends of musculoskeletal procedures are seen to be the biggest driver for the market. Establishing strategic partnerships for the purpose of marketing is also expected to boost the demand for the global orthobiologics market. Several merchants are forming strategic partnerships to diversify their businesses, grow their overall market share and spread out their product offerings. These type of strategic alliances help the organizations to align their technologies with one another’s inventive medical device range.

Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sample

A growth in the global orthobiologics market is projected on account of the requirement for safer, more effective and modern orthopedic biologic treatment. The rise in the number of obesity and arthritis cases also fuels the demand for orthobiologics treatment. The bone graft procedure accounted to be the largest segment in the global orthobiologics market.

The shifting preference to biological implants from mechanical implants is accelerating the growth of this market. Another important trend that is estimated to enhance the growth of the market over next eight years is the increase in funds to improve orthobiologics. Factors such as growing advances in technology, the prevalence of a huge number of chronic and unidentified diseases, initiatives by the government and rise in life expectation may favorably impact the market growth. Along with this, the rising incidences of injuries by sports & road accidents and growing awareness among athletes are also driving the demand for the market.

However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the orthobiologics demand in the market. The improvements in developing alternatives for pharmaceuticals, for making medical treatments more preventive than curative along with the country’s policy for decreasing the deficit in the budget is expected to negatively impact the global orthobiologics market. Furthermore, high costs for the procedure, lack of reliable clinical trial data and strict regulations for the approval of orthobiologics products may pose challenges to the market growth over the forecast period.

The global orthobiologics market has been segmented based on its applications and product types. On the basis of application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma surgery. On the basis of product types, the market has been segmented into bone graft substitutes, bone growth stimulators, and viscosupplements. The bone graft substitutes have further been segmented into demoralized bone matrix (DBM), bone morph genic proteins (BMP), bone allografts, and bone autographs. Additionally, viscosupplements has also been further segmented into single injection viscosupplements, 3-injection viscosupplements, and 5-injection viscosupplements.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/orthobiologics-market

Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on account of huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are intra-articular injections made of hyaluronic acid which helps in the treatment of osteoarthritis.

North America held the majority of the global orthobiologics market in the recent past. The high demand in the market was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the treatment of various diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-Pacific is projected to witness the highest rate of growth for orthobiologics market. This growth will be majorly driven by the Indian and Chinese market on account of a huge number of untapped patient population, economical cost, and medical tourism.

The major industry players operating in the global orthobiologics market include Stryker Corporation, Synthes, Inc., Biomet, Inc., DJO Global, Zimmer Holding, Inc., Medtronic, Inc., and Smith & Nephew, Bacterin International, Inc., DePuySynthes, Inc., Globus Medical, Inc., and Integra LifeSciences Corporation.

Market Segment:

Orthobiologics Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Demineralized Bone Matrix(DBM)

• Allograft

• Bone Morphogenetic Protein (BMP)

• Viscosupplementation

• Synthetic Bone Substitutes

• Stem Cell Therapy

Orthobiologics Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Spinal Fusion

• Trauma Repair

• Reconstructive Surgery

Orthobiologics End-use Outlook (Revenue, USD Billion, 2014 - 2025)

• Hospitals

• Orthopedic Clinics

Orthobiologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America

• U.S

• Canada

• Europe

• Germany

• UK

• Asia Pacific

• Japan

• China

• India

• Latin America

• Brazil

• Mexico

• Middle East and Africa

• South Africa

See More Reports @ https://marketresarch.wordpress.com

#Biotechnology Orthobiologics Market Size Orthobiologics Market Share Orthobiologics Market Trends Orthobiologics Market Analysis

0 notes

vinayakshindeus-blog · 6 years ago

Text

Mesenchymal Stem Cells Market Growth with Worldwide Industry Analysis to 2026

Mesenchymal Stem Cells are also termed as mesenchymal stromal cells. They are self-renewing multipotent cells having the capability to differentiate in an extensive variety of cell types. Mesenchymal stem cells differentiate in vitro into adipocytes, chondrocytes, osteoblasts, myocytes, and ß-pancreatic islets cells. There are several researches currently undertaken related to the development of mesenchymal stem cells treatments that help in repairing bone and cartilage, in cases such as injuries to the knee meniscus or long-term accumulated damage that leads to osteoarthritis.

Mesenchymal Stem Cells Market is anticipated to grow at a CAGR of 7.3% from 2018 to 2026, as per a new research report published by Polaris Market Research.

For more Professional and Technical Insights Request Sample @

http://bit.ly/2QnYzym

The major factors that are boosting the growth in market for Mesenchymal Stem Cells include increasing demand for these stem cells as an effective treatment alternative for knee replacement. Furthermore, the market is driven by the rising elderly population throughout the globe, along with rising prevalence of various chronic diseases such as cancer. Mesenchymal Stem Cells Market is getting positive support by the effective government policies, and funding for research and development activities which is expected to influence the market growth over coming years.

According to the reports published by world health organisation (WHO) the United Nations, by 2050 people aged over 60 will account for more than 20% of the world’s population. Of that 20%, a conservative estimate of 15% is projected to have symptomatic OA, and one-third of these people are anticipated to be affected by severe disabilities. Considering all these factors, the market for mesenchymal stem cells will witness a significant growth in the future.

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Mesenchymal Stem Cells Market, 2017-2026. This report also comprises a detailed geographic analysis of the market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa regions. North America regional analysis includes U.S., Canada, and Mexico. European regional analysis section covers Germany, UK, Italy, and France. While the Asia Pacific region is bifurcated into China, India, and Japan. In 2017, North America Mesenchymal Stem Cells Market was estimated to dominate the market due to supporting factors such as developed healthcare infrastructure, favourable reimbursement schemes, higher healthcare expenditure, and increasing awareness among the population.

Competitive Landscape

Some of the leading companies profiled in the Mesenchymal Stem Cells Market report include Cell Applications, Inc., Cyagen Biosciences Inc. Axol Bioscience Ltd., Cytori Therapeutics Inc., Stem cell technologies Inc., Celprogen, Inc. BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc.

Mesenchymal Stem Cells Market Key Segments: -

Source:

· Bone Marrow

· Umbilical Cord Blood

· Peripheral Blood

· Lung Tissue

· Synovial Tissues

· Amniotic Fluids

· Adipose Tissues

Application:

· Injuries

· Drug Discovery

· Cardiovascular Infraction

· Others

Region:

· North America

o U.S.

o Canada

o Mexico

· Europe

o Germany

o UK

o France

o Italy

· Asia-Pacific

o China

o India

o Japan

· Latin America

o Brazil

· Middle East and Africa

Related Report: https://www.polarismarketresearch.com/industry-analysis/cell-banking-outsourcing-market/

About Us:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Mr. Rohit

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

#healthcare industry

0 notes

ahila-blog1 · 7 years ago

Text

Global Knee Cartilage Repairing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Knee Cartilage Repairing Market :Cartilage is the rubbery and soft material present in bone joints and prevents the friction between the bones. The knee cartilage available in the market include fibrocartilage, articular cartilage, and elastic cartilage. Cartilage damage mainly occurs due to the osteoarticular disease, various physiological conditions, and accidents. Damage to the cartilage restricts normal movements of the knee causing pain and often occurs after traumatic and twisting injuries of the knee. Knee cartilage repair is beneficial for the conditions like delayed unions, slow healing wounds, and malunions.

Knee cartilage repairing market is growing at a significant CAGR due to the increase in the geriatric population. The increase in obese population, rising incidence of sports injuries, osteoarthritis, and chondrodystrophic leading are the major factors driving the growth of knee cartilage repairing market over the forecast period. Technological advancements, the rise in number of accidents & related injuries and increasing demand for minimally invasive surgical products are the key factors boosting the growth of knee cartilage repairing market. However, the high cost of therapy and unfavourable reimbursement scenario are the major restraining factors of the knee cartilage repairing market. Complexities of cartilage repair surgeries are also expected to hamper the growth of knee repairing market over the forecast period.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-knee-cartilage-repairing-market/#ulp-4H8Z4LpNMLEuOnnx

The knee cartilage repairing market is segmented on the basis of treatment modality, by application, procedure type, and end-user.

Based on treatment modality, knee cartilage repairing market has been segmented into the following:

· Cell based approaches

o Chondrocyte Transplantation

o Growth factor technology

o Stem cells

· Non-cell based approaches

o Tissue scaffolds

o Cell-free composites

Based on application, knee cartilage repairing market has been segmented into the following:

· Hyaline cartilage

· Fibrocartilage

Based on procedure type, knee cartilage repairing market has been segmented into the following:

· Arthroscopic Chondroplasty

· Osteochondral grafts transplantation

· Autologous Chondrocyte

· Implants transplant

· Cell-based cartilage resurfacing

· Microfracture

· Others

Based on the end-user, knee cartilage repairing market has been segmented into the following:

· Hospitals

· Orthopaedic Clinics

· Ambulatory surgical centres

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-knee-cartilage-repairing-market/#ulp-c654SbFYO64MsOhu

Rising incidence and prevalence of obesity and diabetes is expected to propel the knee cartilage repairing market over the forecast period. According to the American Heart Association (AHA), the global geriatric population may be increased to 20% of the total population by 2030 which is expected to boost the cartilage repair market over the forecast period. Increase in the road accidents (according to World Health Organization, approximately 1.25 million people die each year in road accidents worldwide), and sports-related injuries (according to American Orthopaedic Society for Sports Medicine, more than 3.5 Mn athletes has received treatment due to sports injuries every year) are expected to fuel the knee cartilage repairing market over the forecast period. Developing technology in the knee cartilage repairing treatment also fuel the growth of knee cartilage repairing market. For instance, the German firm Amedrix GmbH has developed the minimally invasive surgical procedure for the treatment of cartilage defects.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-knee-cartilage-repairing-market/#ulp-14mlyhjMGhVjZqa3

Geographically, knee cartilage repairing market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for a major revenue share in the global market followed by Europe. The factors which are responsible for the growth of knee cartilage repairing market in the region are an increase in geriatric population and rapid degenerative changes of the knees. Furthermore, the growth of the knee cartilage repairing market is partly driven by the expanded access to health insurance coverage in the U.S. through the Medicare and the Medicaid. Rise in prevalence of osteoporosis in France, U.K. (according to National Health Service, over 3 Mn people are affected to osteoporosis in the UK each year), and Germany is anticipated to bolster the knee cartilage repairing market in the Europe region. The presence of skilled healthcare professionals as well as rising bone and joint disorders expected to create the huge demand for surgery products in Germany. Asia Pacific is the most profitable region for knee cartilage repairing market owing to increase in the prevalence of diabetes (according to International Diabetes Federation 2015, approximately 109.6 Mn people were affected with diabetes in China, 1 Mn cases were reported Australia, and 7.2 Mn diabetes cases in Japan), rise in prevalence of osteoporosis in Australia and New Zealand (according to the Osteoporosis Australia over 1 Mn Australians and as per Burden of Osteoporosis in New Zealand (BONZ), the number osteoporosis at different sites in the skeleton was 84,000 cases in 2007, which is expected to reach 116,000 by 2020), increase in demand for elder care and treatment for age related conditions, and rise in medical tourism in Asia Pacific region anticipated to fuel the knee cartilage repairing market over the forecast period. Latin America and Middle East & Africa region are expected to fuel the demand for cartilage repair products during the forecast period due to increase in obese (overweight) population.

Some of the players in knee cartilage repairing market are Medtronic (U.S.), Biomet, Inc. (Zimmer Biomet Inc.) (U.S.), ConMed Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), LifeNet Health, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), Stryker Corporation (U.S.), and Vericel Corporation (U.S.), to name a few.

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-knee-cartilage-repairing-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

#Knee Cartilage Repairing Market #Global Knee Cartilage Repairing Market #Knee Cartilage Repairing Market Scope #Knee Cartilage Repairing Market outline #Knee Cartilage Repairing Market Demand #Knee Cartilage Repairing Market research #Knee Cartilage Repairing Market report

0 notes

medicastemcellsuk · 4 years ago

Text

Does Weather Affect Your Osteoarthritis Condition? – Ask Medical Stem Cells Clinic in the UK

Many patients believe that weather affects their osteoarthritis condition. They complain that rainy weather or colder weather worsens their osteoarthritic symptoms, including joint pain, swelling, and stiffness compared to a warmer and sunnier climate. They even believe that moving to places having warmer weather will reduce their symptoms significantly. Let's try to find out if there is any truth behind this perception.

Is there any scientific evidence to back up this statement?

There is a connection between specific weather patterns and osteoarthritis symptoms. But this was not a piece of solid evidence 2014 research work published in the journal Pain revealed that the relative humidity and barometric pressure affected hip osteoarthritic symptoms in 222 people [1].

A 2007 research work in the American Journal of Medicine revealed that every ten- degree drop in temperature was associated with a slight increase in knee osteoarthritis pain [2].

A 2016 review article published in the Journal of General Practice revealed that the evidence to support the belief that cold weather worsens osteoarthritic symptoms is weak [3]. The researchers revealed that the miserable weather happens to be related to other factors such as mood changes and fatigue that worsen osteoarthritis symptoms.

Whether or not climate makes a difference, you don't have to undergo the symptoms in silence as there are treatments out there that can help you to manage the osteoarthritis symptoms very well.

Conventional treatment for osteoarthritis

Conventional methods may treat the disease by masking the symptoms temporarily. But they don't treat the underlying cause of the disease. The conventional methods include home treatment such as RICE (Rest, Ice therapy, Compression and Elevation) therapy, physical therapy, activity modification, administration of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroid injections. The last resort will be the surgery if the above treatment modalities fail. But surgery is invasive, painful, and involves general anaesthesia. It also has serious risks associated with it. Furthermore, long rehabilitation is required in case of knee or hip replacement surgery.

Regenerative cell therapy for osteoarthritis

At Medical Stem Cells Clinic in London and Ireland provide regenerative therapeutic options such as Platelet Rich Plasma (PRP) and cell therapy to treat osteoarthritis. Regenerative therapies can naturally treat arthritis by enhancing the repair mechanism of the damaged tissues and regenerating the new cells. This non-surgical treatment thereby reduces pain and inflammation. As the cells are harvested from the patient's own body, there is no risk of rejection or allergy. Hence, these minimally invasive therapies are considered as a successful alternative for surgery. By avoiding the painful and extensive surgical process, patients can quickly return to their normal routine lives without any risks.

For more information about the natural regenerative cell treatment for osteoarthritis condition, please feel free to refer to the website http://www.medicastemcells.com. At Medica Stem Cells Clinic in the UK and Ireland, we use platelet-rich plasma (PRP) therapy, prolotherapy, mesenchymal cell therapy combined with physical therapy and nutritional support to treat the cause of osteoarthritis. To learn more about the regenerative cell treatment in detail, contact Medica Stem Cells clinic in London on 020 8 168 2000.

References

Dorleijn DM, Luijsterburg PA, Burdorf A, et al. Associations between weather conditions and clinical symptoms in patients with hip osteoarthritis: a 2-year cohort study. Pain. 2014;155(4):808-813. doi:10.1016/j.pain.2014.01.018

McAlindon T, Formica M, Schmid CH, Fletcher J. Changes in barometric pressure and ambient temperature influence osteoarthritis pain. Am J Med. 2007;120(5):429-434. doi:10.1016/j.amjmed.2006.07.036

Deall, Ciara & Majeed, Haroon. (2016). Effect of Cold Weather on the Symptoms of Arthritic Disease: A Review of the Literature. Journal of General Practice. 4. 10.4172/2329-9126.1000275.

0 notes